Latest Content

10 of 494 Shown
  • Adopting Strategies to Eliminate HCV in Persons Who Inject Drugs

    Frederick L. Altice MD - 1/19/2018
    Eliminating HCV infection among persons who inject drugs is a daunting task whether tackling it from a patient care perspective, through practice transformation, or by influencing policies that improve access to treatment. Nonetheless, there are practical steps that can be taken by clinicians to improve the HCV continuum of care for this challenging population. Here’s my take on some of those steps.
  • Interactive Virtual Presentation cme-icon

    Hepatitis C Update: A Growing Challenge With Evolving Management Solutions

    In this updated CME-certified interactive presentation targeted to primary care clinicians, hepatitis expert Terry D. Box, MD, reviews the changing epidemiology of hepatitis C infections, age- and risk-based HCV screening, follow-up after testing in the primary care and specialist settings, and counseling patients on the benefits of HCV screening and treatment.
    Faculty: Terry D. Box MD, Brian L. Pearlman MD, FACP, FAASLD, Mary Speigle NP
    Released: 1/17/2018
  • How New Data From AASLD 2017 Inform the Use of 8-Week Regimens for HCV

    Ira M. Jacobson MD - 1/9/2018
    How will data presented at AASLD 2017 on 8-week therapy have an impact on management of patients with HCV infection? Here’s my take.
  • New Insights on NAFLD/NASH From AASLD 2017

    Philip Newsome PhD, FRCPE - 1/8/2018
    Here’s my take on how new data from AASLD 2017 on noninvasive imaging modalities and emerging investigational agents may affect the NAFLD/NASH patient management landscape.
  • How Injection Drug Use Affects HCV Treatment

    Norah Terrault MD, MPH - 1/3/2018 1 comment / Last Comment: 1/16/2018
    Here’s my take on why colocalization of HCV treatment with other medical and social services may be ideal for persons who inject drugs.
  • Hepatitis Alert: HCV Elimination—Closing the Gaps in Screening, Care Linkage, and Treatment

    Listen to downloadable audio from a series of live Webinars in which expert faculty review important strategies for closing gaps along the HCV care continuum with a focus on overcoming barriers to reach and treat persons who inject drugs.
    Date Posted: 1/2/2018
  • Hepatitis Alert: HCV Elimination—Closing the Gaps in Screening, Care Linkage, and Treatment

    In this downloadable slideset, Norah Terrault, MD, MPH, and Stacey Trooskin, MD, PhD, review important strategies for closing gaps along the HCV care continuum with a focus on overcoming barriers to reach and treat persons who inject drugs.
    Date Posted: 12/19/2017
  • Interactive Virtual Presentation cme-icon ce-icon

    Expert Insights in Selecting Therapy for Chronic Hepatitis B

    In this CME-certified activity, Tram T. Tran, MD, presents a series of topical case studies featuring patients with chronic hepatitis B, and discusses how our expert faculty chose to manage them.
    Faculty: Tram T. Tran MD
    Released: 12/15/2017
  • Expert Insights in Selecting Therapy for Chronic Hepatitis B

    In this slideset, Dr. Tram T. Tran, MD, discusses expert approaches to selecting HBV therapy in a series of cases studies involving HBV-infected patients.
    Date Posted: 12/15/2017
  • HCV Prevention in Correctional Settings Is Good Medicine

    Lara Strick MD, MS - 12/12/2017 2 comments / Last Comment: 1/16/2018
    Implementation of prevention services targeting incarcerated patients is possible. Let me tell you why.
10 of 494 Shown
Show 10 More
Loading...  
Decision Support
Free
inPractice
Immediate answers to treatment questions
More than just up to date